Premature coronary heart disease (CHD) has emerged as a major cause of morbidity and
mortality in patients with systemic lupus erythematosus (SLE). Overall SLE patients have a 5 …

Objective Inflammatory disease activity in patients with systemic lupus erythematosus (SLE)
may affect the development of atherosclerosis, contributing to their increased risk of …

This review summarises a number of current insights into the pathogenesis of SLE. On the
basis of the interaction of environmental factors within a predisposed host, a chronic …

Objective. Systemic lupus erythematosus (SLE) is associated with accelerated
atherosclerotic cardiovascular disease. Patients with SLE have adverse lipoprotein …

Systemic lupus erythematosus (SLE) is the prototype of autoimmune diseases with
multiorgan involvement. SLE presents many genetic and epigenetic associations and the …

Oxidative stress and LDL modification (oxLDL) are early pro-atherogenic events. OxLDL
binds β2GPI producing immunogenic oxLDL/β2GPI complexes. Antibodies to these …

Atherosclerosis is the major cause of cardiovascular disease (CVD) and in addition to
established risk factors as smoking, hypertension, diabetes and dyslipidemia, inflammation …

Systemic lupus erythematosus (SLE) is an autoimmune disorder that primarily affects young
women and is characterized by inflammation in several organs including kidneys, skin …

Objectives. To study the levels of anti-oxidized low-density lipoprotein (LDL) antibodies in
patients with systemic lupus erythematosus (SLE) at two different points during the disease …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with profound effects
on multiple organ systems. In patients with SLE, the immune system is subverted to target …